Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02508532
Title Phase 1 Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Blueprint Medicines Corporation
Age Groups: adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale Arizona 85258 United States Details
Sarcoma Oncology Center Santa Monica California 90403 United States Details
Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Cancer Treatment Centers of America Atlanta Georgia 30256 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Leuven Cancer Institute University Hospitals Leuven Leuven 3000 Belgium Details
Centre Leon Berard Lyon 69008 France Details
Institut Gustave Roussy Paris 94805 France Details
University of Duisburg-Essen Essen 45122 Germany Details
Fondazione IRCCS - Istituto Nazinale dei Tumori Milan 20133 Italy Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
Erasmus MC Cancer Institute Rotterdam 3015 Netherlands Details
Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie w Warszawie Warsaw 02-781 Poland Details
Vall d' Hebron Institute of Oncology (VHIO) Barcelona 08305 Spain Details
Royal Marsden Hospital London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from for the field